Effects of Negative Pressure Ventilation on Right Ventricular Function in Cardiological Patients
Launched by KARLSBURG HOSPITAL · Aug 23, 2024
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how a treatment called negative pressure ventilation affects the right side of the heart in patients who are undergoing a procedure called tricuspid clipping. This procedure is used to help patients with heart issues, specifically those who have problems with the tricuspid valve, which can lead to a condition known as right ventricular dysfunction. The researchers want to see if using this special type of ventilation can improve heart function compared to the standard way of supporting breathing.
To participate in the trial, patients need to be scheduled for the tricuspid clipping procedure and should not have any serious breathing or heart stability issues. During the trial, participants will first receive standard care, including monitoring their heart and breathing. They will then try out the negative pressure ventilation while their heart function is closely observed. This trial is not yet recruiting, but it aims to gather important information that could help improve care for patients with heart conditions in the future.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • patients planned for tricuspidal clipping
- Exclusion Criteria:
- • ventilatory of hemodynamic instability
- • fitting of cuirass not possible
- • unavailability of examiner
About Karlsburg Hospital
Karlsburg Hospital is a distinguished healthcare institution dedicated to advancing medical research and improving patient outcomes through innovative clinical trials. With a focus on multidisciplinary collaboration, the hospital is committed to conducting high-quality studies that adhere to rigorous ethical standards and regulatory guidelines. By leveraging state-of-the-art facilities and a team of experienced healthcare professionals, Karlsburg Hospital aims to contribute valuable insights to the medical community, ultimately enhancing treatment options and fostering the development of new therapies for a variety of health conditions.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Karlsburg, Mecklenburg Vorpommern, Germany
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported